Great Point Partners completed the acquisition of a majority stake in Lenis for €45m.

Great Point Partners, a private equity firm specializing in healthcare investments, completed the acquisition of a majority stake in Lenis, a full-service specialty pharmaceutical commercialization and distribution company, for €45m. “Every country deserves a strong and reliable pharmaceutical supply chain, and there is no company with the track record, expertise and unparalleled quality and compliance standards in the CEE that matches that of the Lenis Group,” David Slattery, Great Point Partner Principal and Head of the firm’s London office.